MUMBAI, India, Sept. 7 -- Intellectual Property India has published a patent application (202617084298 A) filed by Jiangsu Alphamab Biopharmaceuticals Co. , Ltd. on July 09, 2026, for Multi-Specific Antibody Targeting Her3 And Trop2 And Conjugate Thereof.
Inventors include Xu, Ting; Wang, Ling; Chen, Feier; Liu, Yang; Li, Fan; Shan, Chuankun; Dou, Yaqi; and Peng, Jianjian.
The application for the patent was published on September 04, 2026, under issue no. 36/2026.
Abstract: Provided in the present application are an HER3 single-domain antibody, a multi-specific antigen-binding protein and protein-drug conjugate comprising the single- domain antibody, and the use thereof in the preparation of a drug for treating/preventing tumors.
Disclaimer: Curated by HT Syndication.
